<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39433420</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>21</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Effectiveness of digital health exercise interventions on muscle function and physical performance in older adults with possible, confirmed or severe sarcopenia: a protocol for a systematic review.</ArticleTitle><Pagination><StartPage>e086124</StartPage><MedlinePgn>e086124</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e086124</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2024-086124</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Sarcopenia is characterised by the progressive weakening of muscle function that occurs with age. This condition frequently leads to frailty, disability and even death. Research on sarcopenia prevention is growing. Digital health exercise interventions are increasingly gaining attention in this field, with the rapid advancement of the internet and the influence of the COVID-19. However, there is a lack of empirical support for their effectiveness. Our study aims to assess the effect of digital health exercise intervention on sarcopenia in older persons, specifically focusing on its ability to improve muscle strength, muscle mass and physical performance.</AbstractText><AbstractText Label="METHODS AND ANALYSIS" NlmCategory="METHODS">Searching will be performed in the following 11 databases (Medline, Embase, Cochrane Central Register of Controlled Trials, CINAHL, PsycINFO, WOS, Scopus, CBM, CNKI, WANFANG and VIP) for published trials and 2 trial registries (ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform) for unpublished trials. Google Scholar will be used to find grey literature. The criterion of inclusion will be clinical trials involving digital health exercise interventions in older adults (≥60 years) diagnosed with sarcopenia (possible, confirmed or severe sarcopenia). For data synthesis, we will use a summary table to show the major characteristics of selected trials and a summary graph to demonstrate the risk of bias for each outcome using RoB 2, which will be further discussed in a narrative synthesis. The possibility of meta-analysis for quantitative data will be assessed according to the homogeneity analysis of the trials, using the methods of fixed or random effects model. If meta-analysis is possible, subgroup analysis and sensitivity analysis will be performed as well. Publication bias will be assessed through the use of the funnel plot and Egger's linear regression test when an adequate number of trials are available. Finally, the Grading of Recommendations, Assessment, Development and Evaluation approach will be used to classify the certainty of evidence body into four categories (high, moderate, low and very low).</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION" NlmCategory="BACKGROUND">The findings of the systematic review will be shared through publishing in a peer-reviewed journal and presentation at appropriate conferences. Since we will not be using specific patient data, ethical approval is unnecessary.</AbstractText><AbstractText Label="PROSPERO REGISTRATION NUMBER" NlmCategory="UNASSIGNED">CRD42024516930.</AbstractText><CopyrightInformation>© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Ya</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-4877-2312</Identifier><AffiliationInfo><Affiliation>School of Health Sciences, Faculty of Biology, Medicine &amp; Health, The University of Manchester, Manchester, UK ya.shi@postgrad.manchester.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Nursing &amp; School of Public Health, Yangzhou University, Yangzhou, Jiangsu province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stanmore</LastName><ForeName>Emma</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-4522-5292</Identifier><AffiliationInfo><Affiliation>School of Health Sciences, Faculty of Biology, Medicine &amp; Health, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGarrigle</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-0533-3029</Identifier><AffiliationInfo><Affiliation>School of Health Sciences, Faculty of Biology, Medicine &amp; Health, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Todd</LastName><ForeName>Chris</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6645-4505</Identifier><AffiliationInfo><Affiliation>School of Health Sciences, Faculty of Biology, Medicine &amp; Health, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055948" MajorTopicYN="Y">Sarcopenia</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="Y">Systematic Reviews as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076604" MajorTopicYN="Y">Physical Functional Performance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053580" MajorTopicYN="Y">Muscle Strength</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005081" MajorTopicYN="Y">Exercise Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017216" MajorTopicYN="N">Telemedicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000097103" MajorTopicYN="N">Digital Health</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aged</Keyword><Keyword MajorTopicYN="N">GERIATRIC MEDICINE</Keyword><Keyword MajorTopicYN="N">Protocols &amp; guidelines</Keyword><Keyword MajorTopicYN="N">Systematic Review</Keyword><Keyword MajorTopicYN="N">Telemedicine</Keyword><Keyword MajorTopicYN="N">eHealth</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>4</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>4</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>21</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39433420</ArticleId><ArticleId IdType="pmc">PMC11499845</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2024-086124</ArticleId><ArticleId IdType="pii">bmjopen-2024-086124</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31. doi: 10.1093/ageing/afy169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afy169</ArticleId><ArticleId IdType="pmc">PMC6322506</ArticleId><ArticleId IdType="pubmed">30312372</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes LV, Paiva AEG, Silva ACB, et al. Prevalence of sarcopenia according to EWGSOP1 and EWGSOP2 in older adults and their associations with unfavorable health outcomes: a systematic review. Aging Clin Exp Res. 2022;34:505–14. doi: 10.1007/s40520-021-01951-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-021-01951-7</ArticleId><ArticleId IdType="pubmed">34398438</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Li W-Y, Ho M, et al. The Prevalence of Sarcopenia in Chinese Older Adults: Meta-Analysis and Meta-Regression. Nutrients. 2021;13:1441. doi: 10.3390/nu13051441.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13051441</ArticleId><ArticleId IdType="pmc">PMC8146971</ArticleId><ArticleId IdType="pubmed">33923252</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura A, Seino S, Abe T, et al. Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults. J Cachexia Sarcopenia Muscle. 2021;12:30–8. doi: 10.1002/jcsm.12651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12651</ArticleId><ArticleId IdType="pmc">PMC7890144</ArticleId><ArticleId IdType="pubmed">33241660</ArticleId></ArticleIdList></Reference><Reference><Citation>Choo YJ, Chang MC. Prevalence of Sarcopenia Among the Elderly in Korea: A Meta-Analysis. J Prev Med Public Health. 2021;54:96–102. doi: 10.3961/jpmph.21.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.3961/jpmph.21.046</ArticleId><ArticleId IdType="pmc">PMC8046603</ArticleId><ArticleId IdType="pubmed">33845529</ArticleId></ArticleIdList></Reference><Reference><Citation>Petermann‐Rocha F, Balntzi V, Gray SR, et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis. J cachexia sarcopenia muscle. 2022;13:86–99. doi: 10.1002/jcsm.12783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12783</ArticleId><ArticleId IdType="pmc">PMC8818604</ArticleId><ArticleId IdType="pubmed">34816624</ArticleId></ArticleIdList></Reference><Reference><Citation>Mijnarends DM, Luiking YC, Halfens RJG, et al. Muscle, Health and Costs: A Glance at their Relationship. J Nutr Health Aging. 2018;22:766–73. doi: 10.1007/s12603-018-1058-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12603-018-1058-9</ArticleId><ArticleId IdType="pmc">PMC6061527</ArticleId><ArticleId IdType="pubmed">30080217</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai T, Fang F, Li F, et al. Sarcopenia is associated with hypertension in older adults: a systematic review and meta-analysis. BMC Geriatr. 2020;20:279. doi: 10.1186/s12877-020-01672-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-020-01672-y</ArticleId><ArticleId IdType="pmc">PMC7409686</ArticleId><ArticleId IdType="pubmed">32762638</ArticleId></ArticleIdList></Reference><Reference><Citation>Anagnostis P, Gkekas NK, Achilla C, et al. Type 2 Diabetes Mellitus is Associated with Increased Risk of Sarcopenia: A Systematic Review and Meta-analysis. Calcif Tissue Int. 2020;107:453–63. doi: 10.1007/s00223-020-00742-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00223-020-00742-y</ArticleId><ArticleId IdType="pubmed">32772138</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue Q, Wu J, Ren Y, et al. Sarcopenia predicts adverse outcomes in an elderly population with coronary artery disease: a systematic review and meta-analysis. BMC Geriatr. 2021;21:493. doi: 10.1186/s12877-021-02438-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-021-02438-w</ArticleId><ArticleId IdType="pmc">PMC8439080</ArticleId><ArticleId IdType="pubmed">34521369</ArticleId></ArticleIdList></Reference><Reference><Citation>Attaway A, Bellar A, Dieye F, et al. Clinical impact of compound sarcopenia in hospitalized older adult patients with heart failure. J Am Geriatr Soc. 2021;69:1815–25. doi: 10.1111/jgs.17108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.17108</ArticleId><ArticleId IdType="pmc">PMC8273144</ArticleId><ArticleId IdType="pubmed">33735939</ArticleId></ArticleIdList></Reference><Reference><Citation>Won H-K, Kang Y, An J, et al. Relationship between asthma and sarcopenia in the elderly: a nationwide study from the KNHANES. J Asthma. 2023;60:304–13. doi: 10.1080/02770903.2022.2047716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02770903.2022.2047716</ArticleId><ArticleId IdType="pubmed">35225127</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro HS, Neri SGR, Oliveira JS, et al. Association between sarcopenia and clinical outcomes in chronic kidney disease patients: A systematic review and meta-analysis. Clin Nutr. 2022;41:1131–40. doi: 10.1016/j.clnu.2022.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2022.03.025</ArticleId><ArticleId IdType="pubmed">35430544</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Lam FMH, Leung J, et al. The Predictive Value of Sarcopenia and Falls for 2-Year Major Osteoporotic Fractures in Community-Dwelling Older Adults. Calcif Tissue Int. 2020;107:151–9. doi: 10.1007/s00223-020-00709-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00223-020-00709-z</ArticleId><ArticleId IdType="pmc">PMC7382674</ArticleId><ArticleId IdType="pubmed">32472390</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertschi D, Kiss CM, Beerli N, et al. Impact of sarcopenia on daily functioning: a cross-sectional study among older inpatients. Aging Clin Exp Res. 2022;34:2041–6. doi: 10.1007/s40520-022-02175-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-022-02175-z</ArticleId><ArticleId IdType="pmc">PMC9464162</ArticleId><ArticleId IdType="pubmed">35794312</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng D, Zhang Q, Wang Z, et al. Association Between Sarcopenia and Its Components and Dependency in Activities of Daily Living in Patients on Hemodialysis. J Ren Nutr. 2021;31:397–402. doi: 10.1053/j.jrn.2020.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jrn.2020.08.016</ArticleId><ArticleId IdType="pubmed">33309409</ArticleId></ArticleIdList></Reference><Reference><Citation>Cawthon PM, Travison TG, Manini TM, et al. Establishing the Link Between Lean Mass and Grip Strength Cut Points With Mobility Disability and Other Health Outcomes: Proceedings of the Sarcopenia Definition and Outcomes Consortium Conference. J Gerontol A Biol Sci Med Sci. 2020;75:1317–23. doi: 10.1093/gerona/glz081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glz081</ArticleId><ArticleId IdType="pmc">PMC7447857</ArticleId><ArticleId IdType="pubmed">30869772</ArticleId></ArticleIdList></Reference><Reference><Citation>Roquebert Q, Sicsic J, Santos-Eggimann B, et al. Frailty, sarcopenia and long term care utilization in older populations: a systematic review. J Frailty Aging. 2021;10:272–80. doi: 10.14283/jfa.2021.7.</Citation><ArticleIdList><ArticleId IdType="doi">10.14283/jfa.2021.7</ArticleId><ArticleId IdType="pubmed">34105712</ArticleId></ArticleIdList></Reference><Reference><Citation>Veronese N, Koyanagi A, Cereda E, et al. Sarcopenia reduces quality of life in the long-term: longitudinal analyses from the English longitudinal study of ageing. Eur Geriatr Med. 2022;13:633–9. doi: 10.1007/s41999-022-00627-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41999-022-00627-3</ArticleId><ArticleId IdType="pmc">PMC9151534</ArticleId><ArticleId IdType="pubmed">35212911</ArticleId></ArticleIdList></Reference><Reference><Citation>Koon-Yee Lee G, Chun-Ming Au P, Hoi-Yee Li G, et al. Sarcopenia and mortality in different clinical conditions: A meta-analysis. Osteoporos Sarcopenia. 2021;7:S19–27. doi: 10.1016/j.afos.2021.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.afos.2021.02.001</ArticleId><ArticleId IdType="pmc">PMC8088992</ArticleId><ArticleId IdType="pubmed">33997305</ArticleId></ArticleIdList></Reference><Reference><Citation>Álvarez-Bustos A, Rodríguez-Sánchez B, Carnicero-Carreño JA, et al. Healthcare cost expenditures associated to frailty and sarcopenia. BMC Geriatr. 2022;22:747. doi: 10.1186/s12877-022-03439-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-022-03439-z</ArticleId><ArticleId IdType="pmc">PMC9469617</ArticleId><ArticleId IdType="pubmed">36096728</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagi T, Inoue T, Ogawa M, et al. Sarcopenia affects activities of daily living recovery and hospitalization costs in older adults in convalescent rehabilitation wards. Eur Geriatr Med. 2021;12:1237–45. doi: 10.1007/s41999-021-00552-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41999-021-00552-x</ArticleId><ArticleId IdType="pubmed">34403114</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Tang Y, Stanmore E, et al. Non-pharmacological interventions for community-dwelling older adults with possible sarcopenia or sarcopenia: a scoping review. Arch Gerontol Geriatr. 2023;112:105022. doi: 10.1016/j.archger.2023.105022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archger.2023.105022</ArticleId><ArticleId IdType="pubmed">37084601</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao W, Sun Y, Zhang T, et al. Exercise Programs for Muscle Mass, Muscle Strength and Physical Performance in Older Adults with Sarcopenia: A Systematic Review and Meta-Analysis. Aging Dis. 2020;11:863–73. doi: 10.14336/AD.2019.1012.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2019.1012</ArticleId><ArticleId IdType="pmc">PMC7390512</ArticleId><ArticleId IdType="pubmed">32765951</ArticleId></ArticleIdList></Reference><Reference><Citation>Escriche-Escuder A, Fuentes-Abolafio IJ, Roldán-Jiménez C, et al. Effects of exercise on muscle mass, strength, and physical performance in older adults with sarcopenia: A systematic review and meta-analysis according to the EWGSOP criteria. Exp Gerontol. 2021;151:111420. doi: 10.1016/j.exger.2021.111420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2021.111420</ArticleId><ArticleId IdType="pubmed">34029642</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu P-Y, Huang K-S, Chen K-M, et al. Exercise, Nutrition, and Combined Exercise and Nutrition in Older Adults with Sarcopenia: A Systematic Review and Network Meta-analysis. Maturitas. 2021;145:38–48. doi: 10.1016/j.maturitas.2020.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.maturitas.2020.12.009</ArticleId><ArticleId IdType="pubmed">33541561</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira LF, Scariot EL, da Rosa LHT. The effect of different exercise programs on sarcopenia criteria in older people: A systematic review of systematic reviews with meta-analysis. Arch Gerontol Geriatr. 2023;105:104868. doi: 10.1016/j.archger.2022.104868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archger.2022.104868</ArticleId><ArticleId IdType="pubmed">36402001</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurst C, Robinson SM, Witham MD, et al. Resistance exercise as a treatment for sarcopenia: prescription and delivery. Age Ageing. 2022;51:afac003. doi: 10.1093/ageing/afac003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afac003</ArticleId><ArticleId IdType="pmc">PMC8840798</ArticleId><ArticleId IdType="pubmed">35150587</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan KOW, Yuen PP, Fong BYF, et al. Effectiveness of telehealth in preventive care: a study protocol for a randomised controlled trial of tele-exercise programme involving older people with possible sarcopenia or at risk of fall. BMC Geriatr. 2023;23:845. doi: 10.1186/s12877-023-04535-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-023-04535-4</ArticleId><ArticleId IdType="pmc">PMC10717497</ArticleId><ArticleId IdType="pubmed">38093219</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuan S-H, Chang L-H, Sun S-F, et al. Using exergame-based exercise to prevent and postpone the loss of muscle mass, muscle strength, cognition, and functional performance among elders in rural long-term care facilities: A protocol for a randomized controlled trial. Front Med. 9:1071409. doi: 10.3389/fmed.2022.1071409. n.d.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.1071409</ArticleId><ArticleId IdType="pmc">PMC9792490</ArticleId><ArticleId IdType="pubmed">36582297</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Xu X, Gao S, et al. Effects of Internet-Based Nutrition and Exercise Interventions on the Prevention and Treatment of Sarcopenia in the Elderly. Nutrients. 2022;14:2458. doi: 10.3390/nu14122458.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14122458</ArticleId><ArticleId IdType="pmc">PMC9229368</ArticleId><ArticleId IdType="pubmed">35745187</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong J, Kim J, Kim SW, et al. Effects of home-based tele-exercise on sarcopenia among community-dwelling elderly adults: Body composition and functional fitness. Exp Gerontol. 2017;87:33–9. doi: 10.1016/j.exger.2016.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2016.11.002</ArticleId><ArticleId IdType="pubmed">27838369</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada M, Nishiguchi S, Fukutani N, et al. Mail-Based Intervention for Sarcopenia Prevention Increased Anabolic Hormone and Skeletal Muscle Mass in Community-Dwelling Japanese Older Adults: The INE (Intervention by Nutrition and Exercise) Study. J Am Med Dir Assoc. 2015;16:654–60. doi: 10.1016/j.jamda.2015.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2015.02.017</ArticleId><ArticleId IdType="pubmed">25858281</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Stewart L, Shekelle P. Implementing PRISMA-P: recommendations for prospective authors. Syst Rev. 2016;5:15. doi: 10.1186/s13643-016-0191-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-016-0191-y</ArticleId><ArticleId IdType="pmc">PMC4730599</ArticleId><ArticleId IdType="pubmed">26822481</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1. doi: 10.1186/2046-4053-4-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Shenkin SD, Harrison JK, Wilkinson T, et al. Systematic reviews: guidance relevant for studies of older people. Age Ageing. 2017;46:722–8. doi: 10.1093/ageing/afx105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afx105</ArticleId><ArticleId IdType="pmc">PMC5860219</ArticleId><ArticleId IdType="pubmed">28655142</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Stanmore E, McGarrigle L, et al.  Effectiveness of tele-exercise on muscle function and physical performance in older adults for preventing sarcopenia: a protocol for systematic review. Geriatric Medicine. 2024 doi: 10.1101/2024.03.06.24303856. https://www.crd.york.ac.uk/prospero/ display_record.php?ID=CRD42024516930 Preprint. Available.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.03.06.24303856</ArticleId><ArticleId IdType="pmc">PMC11499845</ArticleId><ArticleId IdType="pubmed">39433420</ArticleId></ArticleIdList></Reference><Reference><Citation>Aslam S, Emmanuel P. Formulating a researchable question: A critical step for facilitating good clinical research. Indian J Sex Transm Dis AIDS. 2010;31:47–50. doi: 10.4103/0253-7184.69003.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0253-7184.69003</ArticleId><ArticleId IdType="pmc">PMC3140151</ArticleId><ArticleId IdType="pubmed">21808439</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowal P, Dowd JE. Definition of an Older Person. Proposed Working Definition of an Older Person in Africa for the MDS Project. Geneva: World Health Organization; 2001.</Citation></Reference><Reference><Citation>Orimo H, Ito H, Suzuki T, et al. Reviewing the definition of “elderly.”. Geriatrics Gerontology Int . 2006;6:149–58. doi: 10.1111/j.1447-0594.2006.00341.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1447-0594.2006.00341.x</ArticleId><ArticleId IdType="pubmed">16521795</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouchi Y, Rakugi H, Arai H, et al. Redefining the elderly as aged 75 years and older: Proposal from the Joint Committee of Japan Gerontological Society and the Japan Geriatrics Society. Geriatr Gerontol Int. 2017;17:1045–7. doi: 10.1111/ggi.13118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ggi.13118</ArticleId><ArticleId IdType="pubmed">28670849</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412–23. doi: 10.1093/ageing/afq034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afq034</ArticleId><ArticleId IdType="pmc">PMC2886201</ArticleId><ArticleId IdType="pubmed">20392703</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L-K, Liu L-K, Woo J, et al. Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15:95–101. doi: 10.1016/j.jamda.2013.11.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2013.11.025</ArticleId><ArticleId IdType="pubmed">24461239</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L-K, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020;21:300–7. doi: 10.1016/j.jamda.2019.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2019.12.012</ArticleId><ArticleId IdType="pubmed">32033882</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinícius-Souza GE, Noll M, Silveira EA. Effectiveness of exercise for osteosarcopenia in older adults: a systematic review protocol. BMJ Open. 2021;11:e045604. doi: 10.1136/bmjopen-2020-045604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-045604</ArticleId><ArticleId IdType="pmc">PMC8256791</ArticleId><ArticleId IdType="pubmed">34215601</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouzzani M, Hammady H, Fedorowicz Z, et al. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5:210. doi: 10.1186/s13643-016-0384-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-016-0384-4</ArticleId><ArticleId IdType="pmc">PMC5139140</ArticleId><ArticleId IdType="pubmed">27919275</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi: 10.1136/bmj.l4898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l4898</ArticleId><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn E, Kang H. Introduction to systematic review and meta-analysis. Korean J Anesthesiol. 2018;71:103–12. doi: 10.4097/kjae.2018.71.2.103.</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kjae.2018.71.2.103</ArticleId><ArticleId IdType="pmc">PMC5903119</ArticleId><ArticleId IdType="pubmed">29619782</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo D, Wan X, Liu J, et al. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27:1785–805. doi: 10.1177/0962280216669183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280216669183</ArticleId><ArticleId IdType="pubmed">27683581</ArticleId></ArticleIdList></Reference><Reference><Citation>Afroditi K, Sofia T. Handling Heterogeneity in Cochrane Reviews. 2023. https://training.cochrane.org/sites/training.cochrane.org/files/public/uploads/Handling%20heterogeneity%20in%20Cochrane%20reviews.pdf Available.</Citation></Reference><Reference><Citation>Thabane L, Mbuagbaw L, Zhang S, et al. A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. BMC Med Res Methodol. 2013;13:92. doi: 10.1186/1471-2288-13-92.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-13-92</ArticleId><ArticleId IdType="pmc">PMC3720188</ArticleId><ArticleId IdType="pubmed">23855337</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34. doi: 10.1136/bmj.315.7109.629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Doleman B, Freeman SC, Lund JN, et al. Funnel plots may show asymmetry in the absence of publication bias with continuous outcomes dependent on baseline risk: presentation of a new publication bias test. Res Synth Methods. 2020;11:522–34. doi: 10.1002/jrsm.1414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1414</ArticleId><ArticleId IdType="pubmed">32362052</ArticleId></ArticleIdList></Reference><Reference><Citation>Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455–63. doi: 10.1111/j.0006-341x.2000.00455.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0006-341x.2000.00455.x</ArticleId><ArticleId IdType="pubmed">10877304</ArticleId></ArticleIdList></Reference><Reference><Citation>Elia N, von Elm E, Chatagner A, et al. How do authors of systematic reviews deal with research malpractice and misconduct in original studies? A cross-sectional analysis of systematic reviews and survey of their authors. BMJ Open. 2016;6:e010442. doi: 10.1136/bmjopen-2015-010442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2015-010442</ArticleId><ArticleId IdType="pmc">PMC4785311</ArticleId><ArticleId IdType="pubmed">26936908</ArticleId></ArticleIdList></Reference><Reference><Citation>Brozek JL, Akl EA, Alonso-Coello P, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy. 2009;64:669–77. doi: 10.1111/j.1398-9995.2009.01973.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1398-9995.2009.01973.x</ArticleId><ArticleId IdType="pubmed">19210357</ArticleId></ArticleIdList></Reference><Reference><Citation>Balshem H, Helfand M, Schünemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64:401–6. doi: 10.1016/j.jclinepi.2010.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.07.015</ArticleId><ArticleId IdType="pubmed">21208779</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>